| Obesity in percutaneous nephrolithotomy. Is body mass index really important? CT Ortiz, AIM Martínez, AJV Morton, HV Reyes, SC Feixas, JFS Novo, ... Urology 84 (3), 538-543, 2014 | 68 | 2014 |
| Comparison of biopsy devices in upper tract urothelial carcinoma A Breda, A Territo, F Sanguedolce, G Basile, JD Subiela, HV Reyes, ... World Journal of Urology 37, 1899-1905, 2019 | 47 | 2019 |
| Adjuvant single-dose upper urinary tract instillation of mitomycin C after therapeutic ureteroscopy for upper tract urothelial carcinoma: a single-centre prospective non … A Gallioli, R Boissier, A Territo, H Vila Reyes, F Sanguedolce, JM Gaya, ... Journal of Endourology 34 (5), 573-580, 2020 | 42 | 2020 |
| The role of 18F-FDG PET/CT in guiding precision medicine for invasive bladder carcinoma A Girard, H Vila Reyes, H Shaish, JF Grellier, L Dercle, PY Salaün, ... Frontiers in Oncology 10, 565086, 2020 | 30 | 2020 |
| Carcinoma in situ of the urinary bladder: a systematic review of current knowledge regarding detection, treatment, and outcomes JD Subiela, OR Faba, FG Ramos, HV Reyes, F Pisano, A Breda, J Palou European Urology Focus 6 (4), 674-682, 2020 | 28 | 2020 |
| Treatment options and predictive factors for recurrence and cancer-specific mortality in bladder cancer after renal transplantation: a multi-institutional analysis OR Faba, J Palou, HV Reyes, L Guirado, A Palazzetti, P Gontero, ... Actas Urológicas Españolas (English Edition) 41 (10), 639-645, 2017 | 18 | 2017 |
| Robotic radical cystectomy. JM Gaya, H Vila-Reyes, P Gavrilov, A Territo, A Breda, J Palou Archivos Espanoles de Urologia 72 (3), 293-298, 2019 | 8 | 2019 |
| A machine-learning-based combination of criteria to detect bladder cancer lymph node metastasis on [18F]FDG PET/CT: a pathology-controlled study A Girard, L Dercle, H Vila-Reyes, LH Schwartz, A Girma, M Bertaux, ... European Radiology 33 (4), 2821-2829, 2023 | 5 | 2023 |
| Residual urinary volume is a risk factor for primary nonfunction in kidney transplantation JM Cruzado, A Manonelles, H Vila, E Melilli, N Sala, O Bestard, J Torras, ... Transplant International 28 (11), 1276-1282, 2015 | 5 | 2015 |
| The role of cost-effectiveness analysis in patient-centered cancer care in the era of precision medicine F Toscano, A Vera, E Kim, D Golinelli, H Vila-Reyes, F Bteich, ... Cancers 13 (17), 4272, 2021 | 3 | 2021 |
| Updates on intravesical therapy F Pisano, HV Reyes, A Breda, J Palou Current Opinion in Urology 29 (6), 649-655, 2019 | 3 | 2019 |
| Breakthrough in imaging-guided precision medicine in oncology A Shaw, RD Seban, FL Besson, H Vila-Reyes, S AMMARI, FZ Mokrane, ... Frontiers in Oncology, 2193, 2022 | 2 | 2022 |
| Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a … H Vila-Reyes, GJ DeCastro, JM McKiernan European Urology 79 (1), e35-e36, 2020 | 2 | 2020 |
| Oncologic outcomes of complete transurethral resection prior to neoadjuvant chemotherapy for muscle-invasive bladder cancer. JS Pak, CR Haas, H Vila Reyes, CB Anderson, GJ DeCastro, MC Benson, ... Journal of Clinical Oncology 38 (15_suppl), e17029-e17029, 2020 | 2 | 2020 |
| Technical data on upper tract urothelial carcinoma (UTUC) grading using 3 different biopsy devices A Territo, A Breda, G Basile, HV Reyes, JD Subiela, O Mayordomo, ... European Urology Supplements 17 (2), e1614, 2018 | 2 | 2018 |
| Sientific program of 36th World Congress of endourology Programm Book M Takhar, M Alshalalfa, A Gupta, S Prasad J. Endourol 32, P1-A573, 2018 | 2 | 2018 |
| Long-term oncologic outcomes in patients with muscle invasive bladder cancer misclassified as achieving a complete clinical response to neoadjuvant chemotherapy R Chung, JT Kurtzman, BI Joffe, H Vila-Reyes, CH Miles, GJ DeCastro, ... JU Open Plus 2 (9), e00088, 2024 | 1 | 2024 |
| Future role of [18F]-FDG PET/CT in patients with bladder cancer in the new era of neoadjuvant immunotherapy? A Girard, HV Reyes, L Dercle, M Rouanne Urologic Oncology: Seminars and Original Investigations 39 (2), 139-141, 2021 | 1 | 2021 |
| MP73-09 EFFECTIVENESS OF COMBINATION CISPLATIN-BASED INTRAVESICAL CHEMOTHERAPY FOR BCG-REFRACTORY BLADDER CANCER H Vila-Reyes, GJ Decastro, I Faiena, JS Pak, K Lee, G Li, CB Anderson, ... Journal of Urology 203, e1124, 2020 | 1 | 2020 |
| Radiation cystitis after prostate cancer radiotherapy: risk factors associated to hospital admission and intervention F Sanguedolce, F Pisano, GS Pardo, E Acosta, AM Sanchez, JB Lucena, ... European Urology Supplements 17 (2), e1634, 2018 | 1 | 2018 |
Andrea GallioliDepartment of Urology, Puigvert Foundation, Autonomous University of Barcelona, Barcelona, Spain在 fundacio-puigvert.es 的电子邮件经过验证
